logo-loader
viewIdenta Corp.

IDenta Corp. gets U.S. patent approval for drugs and explosives detection device

IDenta Corp. (OTCMKTS:IDTA) COO Amichai Glattstein tells Proactive Investors that the drugs and explosives detection specialist has received formal approval from the U.S. Patent Office for its AeroChamber product.

Glattstein says the Israeli company has additional patents in the U.S. market where it has strategic partners in Indiana and in Illinois.

Quick facts: Identa Corp.

Price: 0.4 USD

OTCMKTS:IDTA
Market: OTCQB
Market Cap: $1.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: TRACON Pharmaceuticals reveals its low-cost drug development...

TRACON Pharmaceuticals (NASDAQ:TCON) CEO Charles Theuer tells Proactive the biotechnology company ended 2019 with cash, cash equivalents and short-term investments of $16.4 million. Theuer explains despite engaging in five different clinical trials, three of the five company's clinical trials...

12 hours, 23 minutes ago

2 min read